Interventional Oncology - TheraSphere - Sequencing TheraSphere with systemic treatments including immunotherapies and chemotherapies

Proposals may be submitted at any time and will be reviewed on a quarterly basis throughout 2021. All submissions must be in full proposal form to be reviewed by committee, to render a formal decision.

Start Date:

1/27/2021

End Date:

12/31/2021

Franchise:

Interventional Oncology